Is transglutaminase the mediator between antimalarial drugs and psoriasis?
Wolf
R
R
Maccabee Outpatient Clinic, Tel-Aviv University, Israel.
Lo Schiavo
A
A
D000962:Antimalarials / Q000009:adverse effects* / Q000494:pharmacology; D006801:Humans; D011565:Psoriasis / Q000139:chemically induced* / Q000201:enzymology / Q000503:physiopathology; D011503:Transglutaminases / Q000378:metabolism / Q000502:physiology*
D000962:Antimalarials; D011503:Transglutaminases